Ipilimumab with fotemustine in metastatic melanoma

Lancet Oncol. 2012 Sep;13(9):851-2. doi: 10.1016/S1470-2045(12)70341-8. Epub 2012 Aug 13.

Author

Affiliation

¹ Division of Dermatooncology, Department of Dermatology, University Medical Center, 72074 Tuebingen, Germany. claus.garbe@med.uni-tuebingen.de

PMID: 22894885
DOI: 10.1016/S1470-2045(12)70341-8

No abstract available

Publication types

Comment

MeSH terms

Antibodies, Monoclonal / administration & dosage*
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
Brain Neoplasms / secondary*
Female
Humans
Ipilimumab
Male
Melanoma / drug therapy*
Melanoma / secondary*
Nitrosourea Compounds / administration & dosage*
Organophosphorus Compounds / administration & dosage*
Skin Neoplasms / drug therapy*

Substances

Antibodies, Monoclonal
Ipilimumab
Nitrosourea Compounds
Organophosphorus Compounds
fotemustine